If you’ve ever tried to figure out whether Ozempic, Mounjaro, Zepbound, or Wegovy is covered by your insurance, you’ve probably run into a wall of “it depends.” Which is technically accurate — but not very helpful when you’re trying to figure out whether you can actually afford this medication.
So let’s make it less confusing. The short version: coverage in Canada comes down to two things — why you’re taking a GLP-1, and what plan you have. Those two factors determine almost everything.
Here’s how it actually works.
The Biggest Factor — What It’s Prescribed For
This is the thing most people don’t realize until their claim gets denied, so it’s worth being clear upfront.
GLP-1 medications in Canada are approved for two different indications (meaning two different medical purposes), and insurance treats them very differently:
Type 2 diabetes — If your GLP-1 is prescribed because you have type 2 diabetes, coverage is relatively established. Many private insurance plans cover drugs like Ozempic and Mounjaro for diabetes. Provincial drug benefit programs (including Alberta’s) also cover them for diabetes with special authorization. It’s not automatic — you still usually need your doctor to submit a form — but the pathway is well-worn.
Weight management / obesity — If you’re taking it purely for weight loss and don’t have type 2 diabetes, coverage is harder. Some private plans have started covering Wegovy or Zepbound for weight management, especially when there are other health conditions involved (high blood pressure, sleep apnea, high cholesterol). But many plans still exclude weight loss medications entirely, or only cover them under strict criteria. Provincial government plans in Alberta don’t currently cover GLP-1s for weight loss at all.
Here’s the honest truth: if weight loss is your only indication, you may end up paying out of pocket for a while. That doesn’t mean you shouldn’t try — coverage is expanding and appeals do succeed — but it’s good to go in with realistic expectations.
Private Insurance — What to Actually Ask Your Plan
If you have extended health benefits through your employer (or a personal plan), start here. Don’t assume you’re not covered — call your insurer and ask directly.
The question to ask: “Does my plan cover [medication name] and for what indications?”
Write down the date, time, and name of the person you spoke with. Insurance coverage interpretations can vary between representatives, and having a paper trail matters if you need to appeal later.
What they’ll likely tell you:
- “Yes, with special authorization” — Your doctor needs to complete a form. This is the most common answer for diabetes coverage. It’s doable.
- “Yes, it’s covered” — Lucky you. Fill the prescription and submit the claim.
- “No, it’s not on our formulary” — Ask whether an appeal process exists, and whether your doctor can submit a request for exception.
- “It’s excluded under our weight loss drug exclusion” — Many plans have a blanket exclusion for weight loss medications. You can appeal this if your doctor documents obesity as a medical condition with comorbidities, not just a lifestyle concern.
One more thing: your pharmacist can also run a “benefit check” before you even call your insurer. They have direct access to most insurance plan formularies and can tell you quickly whether a drug is likely covered and at what tier.
Special Authorization — What It Is and How It Works
You’ll see “special authorization” (sometimes called SA or prior authorization) mentioned constantly when it comes to GLP-1 coverage. Here’s what it actually means.
Special authorization is a process where your doctor formally requests that your insurance plan (or provincial drug benefit) approve coverage for a medication that isn’t automatically covered. It’s not a fight or an appeal — it’s the standard process for many specialized or higher-cost medications.
Your doctor fills out a form that includes:
- Your diagnosis
- Relevant lab values (HbA1c for diabetes, BMI and comorbidities for weight loss)
- What other treatments you’ve tried
- Why this medication is clinically appropriate for you
You don’t fill this out yourself. Your doctor does, and their office has almost certainly done it before. If they haven’t, Eli Lilly’s myMounjaro program and Novo Nordisk’s NovoCare program both offer support navigating SA paperwork.
Alberta timelines: Alberta Health typically processes SA requests within 5–15 business days. Private insurance timelines vary by plan but are usually similar.
Key tip: Don’t wait until you’re out of medication to start the SA process. Start it when you get your prescription. There’s often a gap between first prescription and first covered fill — you want that gap to be as short as possible.
Provincial Drug Coverage — The Alberta Picture
Each province has its own drug benefit program, and they all have different formularies and rules. Here’s where things stand for Alberta specifically, since that’s the focus of this site.
Alberta Drug Benefit (ADB)
The Alberta Drug Benefit program covers a range of GLP-1 medications for patients with type 2 diabetes, with special authorization. As of 2026, both semaglutide (Ozempic) and tirzepatide (Mounjaro) are on the ADB list with SA criteria.
What this means practically: once your doctor’s SA request is approved, the provincial plan picks up most or all of the cost — often to a small co-pay, or free for patients in certain benefit categories (seniors, low income, disability).
What ADB does NOT cover: GLP-1 medications for weight loss as a primary indication. If you don’t have type 2 diabetes, you’re not eligible for provincial drug coverage under the current Alberta formulary. This is a gap that patient and physician advocacy groups are actively pushing to change.
Other provinces at a glance:
- Ontario Drug Benefit — covers GLP-1s for diabetes for eligible Ontarians (social assistance recipients, seniors, certain programs). Private insurance is the main route for employed adults.
- BC PharmaCare — income-based program; Fair PharmaCare calculates co-pays based on family income, which can meaningfully reduce cost for lower-income patients.
- Other provinces vary considerably — your pharmacist is the fastest way to find out what’s on your provincial formulary.
What to Do If You’re Denied
Getting a denial is frustrating, but it’s not necessarily the end of the road. A lot of first-time denials are successfully reversed.
Here’s a practical sequence:
Step 1: Get the denial in writing. Ask your insurer for the specific reason for the denial, in writing. This tells you exactly what you’re appealing.
Step 2: Talk to your doctor. Share the denial reason. If coverage was denied because of insufficient clinical documentation, your doctor can resubmit with more detail — specific BMI, comorbidities, medications already tried, etc. A letter from your physician explaining the medical necessity of the medication is the single most effective appeal tool.
Step 3: Submit a formal appeal. Your insurer is required to have an appeal process. Use it. Appeals supported by physician letters and documented clinical need have a meaningful success rate — don’t treat a first denial as final.
Step 4: Check whether your employer can help. Some employers with group benefits have HR resources that can advocate on your behalf with the insurer. It’s worth asking.
Step 5: Explore alternatives while you wait. See our savings programs page for manufacturer support, patient assistance programs, and ways to reduce out-of-pocket cost during the coverage process.
A Few Things That Actually Help
Based on how GLP-1 coverage works in Canada, here are the moves that make the most difference:
Use the right diagnosis language. “Obesity” is a medical diagnosis. “Weight loss” is a lifestyle goal. On your SA form and in any insurance documentation, make sure your doctor frames this as treatment for obesity with documented comorbidities — not just a desire to lose weight. This matters more than most people realize.
Don’t stop and restart while you’re fighting for coverage. Stopping and restarting GLP-1 medications means going back to the starting dose and escalating again. If you can keep paying out of pocket while your appeal is in progress, that’s usually better than pausing treatment.
Generic semaglutide changes the math for some people. If Ozempic coverage is what you’re fighting for and budget is the issue, generic semaglutide (now available in Canada at roughly half the cost) may be worth discussing with your doctor while you sort out the coverage situation. See our generic Ozempic page for the full picture.
Your pharmacist is an underused resource. They know your provincial formulary, they can run benefit checks, they can flag substitution options, and they can help you navigate SA paperwork. If you haven’t talked to your pharmacist yet, that’s the first call to make.
The Questions We Hear Most
Is Ozempic covered by insurance in Canada? For type 2 diabetes, yes — many private plans cover Ozempic, usually with special authorization from your doctor. For weight loss only, coverage is inconsistent and often requires a formal appeal or documentation of obesity with other health conditions.
Is Mounjaro covered by insurance in Canada? Same situation as Ozempic: covered by many plans for type 2 diabetes with special authorization. For weight loss, coverage is harder to get but not impossible. Zepbound (the weight-management version of tirzepatide) is increasingly being submitted for weight management coverage.
Does Alberta Health cover GLP-1 medications? Yes, for type 2 diabetes with special authorization through the Alberta Drug Benefit program. No, not currently for weight loss as a primary indication.
What does “special authorization” mean? It means your doctor submits a form to your insurance plan or provincial drug benefit explaining why this medication is medically necessary for you. It’s standard for many specialized medications — not a red flag or an unusual request. Most plans process SA requests within two weeks.
My insurer denied my claim. Can I appeal? Yes. All Canadian insurers are required to have a formal appeal process. The most effective appeals include a detailed physician letter documenting the medical necessity, specific clinical data (BMI, comorbidities, medications tried), and a reference to the denial reason. Don’t accept a first denial as final.
Will coverage improve as these medications become more common? Almost certainly, over time. Several provinces are actively reviewing their formulary policies on GLP-1s for obesity, and private insurers are updating their formularies as the evidence base grows. Coverage that doesn’t exist today for weight management may exist in 2027 or 2028.
Sources:
- Alberta Drug Benefit List — tirzepatide and semaglutide coverage criteria (alberta.ca)
- Health Canada — approved indications for semaglutide and tirzepatide products
- Canadian Life and Health Insurance Association (CLHIA) — insured benefits guidance
- Alberta Health special authorization forms and timelines
- Ontario Drug Benefit Program formulary (ontario.ca)
- BC PharmaCare Fair PharmaCare program (gov.bc.ca)
Suggested internal links:
- /savings — GLP-1 savings programs and cost reduction options while you wait for coverage
- /cost/mounjaro-cost-canada — what you’ll pay out of pocket if coverage doesn’t come through
- /generic-ozempic-canada — a more affordable semaglutide option now available in Canada
- /alberta — provincial context for Alberta patients
- /alberta-special-authorization — how the Alberta SA process works, step by step
- /mounjaro-canada and /ozempic-canada — the drugs most commonly submitted for coverage
Last updated: May 2026 | GLP1Directory.ca Coverage information reflects Canadian insurance and provincial drug benefit policies as of May 2026. Insurance coverage varies by plan and is subject to change. This page is for informational purposes only and does not constitute medical, financial, or legal advice. Always confirm your specific coverage with your insurer and speak with your doctor about your treatment options.